Gender differences in perceived costs of safer injection among injection drug use

注射吸毒者对更安全注射的感知成本存在性别差异

基本信息

  • 批准号:
    7574428
  • 负责人:
  • 金额:
    $ 1.39万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-04-01 至 2009-09-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): High-risk drug injection behavior (e.g., injecting with shared syringes, cookers, cotton, and/or water, or splitting drugs with shared syringes) is a significant route of transmission for human immunodeficiency virus (HIV) among IDUs. Though reductions in HIV risk behavior among IDUs have been observed in recent years, residual injection risk behavior persists. For example, from 2000 to 2003, 38% of California syringe exchange program (SEP) participants reported syringe sharing and up to 62% reported paraphernalia sharing. Significant gender differences exist in HIV risk among IDUs. Among women, injection-related risk is often associated with the social and environmental context in which they use drugs, whereas this influence appears to be less significant among men. Several individual-level, cognitive behavioral theories have been used to explain risky injection practices, employing constructs such as perceived susceptibility, perceived severity, self-efficacy, response efficacy, social norms, and HIV knowledge. To date, theoretically-based studies have had mixed success in explaining injection risk behavior using these constructs. Few studies have examined the association between perceived costs or barriers to safer injection and injection risk, and even fewer have examined gender differences in the explanatory power of these theoretical models. These omissions may partially explain the inconsistent results reported by existing studies. In order to more fully understand the persistence of injection risk behavior, the proposed study will test a theoretical model that integrates both individual-level cognitive and environmental- level factors in the form of perceived costs of safer injection. The model incorporates constructs from several cognitive theoretical models, with a focus on the moderating influence of perceived costs and gender. The proposed study will collect data from 20 semi-structured, qualitative interviews and 200 cross- sectional, quantitative interviews with IDUs recruited from a Los Angeles, California SEP. The sample will be ethnically diverse and 33% female. The study has four specific aims: 1) Identify the perceived costs associated with safer injection behavior via qualitative interviews and develop a measure of perceived costs that will be used in a quantitative survey; 2) Assess the relationship between HIV-related cognitive factors and injection risk behavior; 3) Use Structural Equation Modeling (SEM) to explore the moderating influence of perceived costs on the association between other cognitive variables and injection risk behavior; and 4) Use SEM to explore gender differences in perceived costs and in the strength of associations between cognitive and behavioral variables. Findings from the proposed study could be used to design interventions to mitigate the social and environmental costs of safer injection among IDUs, and specifically to help alleviate barriers to safer injection among female IDUs. If the costs of safer behavior can be minimized, IDUs may be more likely to act upon existing HIV cognitions to reduce their injection-related risk behavior. By identifying those factors that contribute to persistent injection-related risk for HIV among injection drug users, interventions designed to address those factors can be developed. Specifically, this study will identify the perceived costs of safer injection behavior, allowing for the development of HIV prevention interventions designed to mitigate the costs of safer behavior. Additionally, a detailed understanding of how these factors differ by gender will help in the design and implementation of tailored interventions that take into account the social and environmental context of both men and women, and those factors that contribute to elevated risk for HIV among women.
描述(由申请人提供):高危药物注射行为(例如共用注射器、炊具、棉花和/或水注射,或共用注射器分裂药物)是注射者之间人类免疫缺陷病毒(HIV)传播的重要途径。尽管近年来观察到注射吸毒者的艾滋病毒风险行为有所减少,但残留注射风险行为仍然存在。例如,从2000年到2003年,38%的加州注射器交换计划(SEP)参与者报告共用注射器,高达62%的参与者报告共用器具。注射吸毒者的艾滋病毒风险存在显著的性别差异。在妇女中,与注射有关的风险往往与她们使用毒品的社会和环境背景有关,而这种影响在男子中似乎不那么显著。一些个体层面的认知行为理论已经被用来解释高风险注射行为,包括感知易感性、感知严重性、自我效能、反应效能、社会规范和艾滋病知识。迄今为止,基于理论的研究在解释使用这些结构的注射风险行为方面取得了不同程度的成功。很少有研究调查了感知成本或安全注射障碍与注射风险之间的关系,更少的研究调查了这些理论模型解释能力的性别差异。这些遗漏可能部分解释了现有研究报告的不一致结果。为了更充分地了解注射风险行为的持久性,本研究将测试一个理论模型,该模型以更安全注射的感知成本的形式整合了个人层面的认知和环境层面的因素。该模型结合了几个认知理论模型的结构,重点关注感知成本和性别的调节影响。拟议的研究将收集20个半结构化定性访谈和200个横断面定量访谈的数据,这些访谈来自加利福尼亚州洛杉矶的SEP。样本将是种族多样化的,其中33%是女性。该研究有四个具体目标:1)通过定性访谈确定与更安全注射行为相关的感知成本,并制定将用于定量调查的感知成本衡量标准;2)评估hiv相关认知因素与注射危险行为的关系;3)利用结构方程模型(SEM)探讨感知成本对其他认知变量与注射风险行为关联的调节作用;4)利用扫描电镜探讨感知成本的性别差异以及认知变量和行为变量之间的关联强度。该研究的结果可用于设计干预措施,以减轻注射吸毒者中更安全注射的社会和环境成本,特别是帮助减轻女性注射吸毒者中更安全注射的障碍。如果安全行为的成本能够最小化,注射吸毒者可能更有可能根据现有的艾滋病毒认知采取行动,以减少与注射相关的危险行为。通过确定导致注射吸毒者持续存在与注射有关的艾滋病毒感染风险的因素,就可以制定旨在解决这些因素的干预措施。具体而言,本研究将确定安全注射行为的感知成本,从而允许开发旨在减轻安全行为成本的艾滋病毒预防干预措施。此外,详细了解这些因素如何因性别而异,将有助于设计和实施有针对性的干预措施,考虑到男性和女性的社会和环境背景,以及那些导致妇女感染艾滋病毒风险增加的因素。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Karla D. Wagner其他文献

Reconciling Incongruous Qualitative and Quantitative Findings in Reconciling Incongruous Qualitative and Quantitative Findings in Mixed Methods Research: Exemplars from Research with Drug Mixed Methods Research: Exemplars from Research with Drug Using Populations Using Populations
协调不一致的定性和定量结果 协调混合方法研究中不一致的定性和定量结果:药物混合方法研究的范例 药物使用人群研究的范例 使用人群
  • DOI:
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Karla D. Wagner;Peter J. Davidson;R. Pollini;Steffanie A. Strathdee;Rachel;Washburn;L. A. Palinkas
  • 通讯作者:
    L. A. Palinkas
Certified peer recovery support specialists and substance use related emergency department visits: A mixed methods study of the patient experience
  • DOI:
    10.1016/j.josat.2024.209563
  • 发表时间:
    2025-02-01
  • 期刊:
  • 影响因子:
  • 作者:
    Mia Rae Kirk;Haley Etchart;Jon Soske;Robert W. Harding;Elizabeth A. Samuels;Stephanie Woodard;Roy F. Oman;Karla D. Wagner
  • 通讯作者:
    Karla D. Wagner
Penalised estimation of partially linear additive zero-inflated Bernoulli regression models
部分线性加性零膨胀伯努利回归模型的惩罚估计
  • DOI:
    10.1080/10485252.2023.2275056
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    1.2
  • 作者:
    Minggen Lu;Chin;Karla D. Wagner
  • 通讯作者:
    Karla D. Wagner
Transitions in polydrug use among heroin and methamphetamine injectors in Tijuana, Mexico
  • DOI:
    10.1016/j.drugalcdep.2014.09.471
  • 发表时间:
    2015-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Meredith C. Meacham;Karla D. Wagner;Timothy Mackey;T.L. Patterson;Steffanie Strathdee;Scott Roesch
  • 通讯作者:
    Scott Roesch
Use of synthetic drugs among people who inject drugs in San Diego, CA
  • DOI:
    10.1016/j.drugalcdep.2014.02.650
  • 发表时间:
    2014-07-01
  • 期刊:
  • 影响因子:
  • 作者:
    Karla D. Wagner;J. Cuevas-Mota;R.F. Armenta;Steffanie Strathdee;R.S. Garfein
  • 通讯作者:
    R.S. Garfein

Karla D. Wagner的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Karla D. Wagner', 18)}}的其他基金

A network-based, mixed methods study to identify and support multiple overdose responders and inform overdose prevention interventions
一项基于网络的混合方法研究,旨在识别和支持多个药物过量反应者并为药物过量预防干预措施提供信息
  • 批准号:
    10590120
  • 财政年份:
    2022
  • 资助金额:
    $ 1.39万
  • 项目类别:
Networks and normative influences on sex and drug-related HIV risk in black women
网络和规范对黑人女性性和毒品相关艾滋病毒风险的影响
  • 批准号:
    8770480
  • 财政年份:
    2015
  • 资助金额:
    $ 1.39万
  • 项目类别:
Sex/Drug Tourism at the US/Mexico Border: Social Network Influences on HIV Risk.
美国/墨西哥边境的性/毒品旅游:社交网络对艾滋病毒风险的影响。
  • 批准号:
    8528531
  • 财政年份:
    2010
  • 资助金额:
    $ 1.39万
  • 项目类别:
Sex/Drug Tourism at the US/Mexico Border: Social Network Influences on HIV Risk.
美国/墨西哥边境的性/毒品旅游:社交网络对艾滋病毒风险的影响。
  • 批准号:
    8318843
  • 财政年份:
    2010
  • 资助金额:
    $ 1.39万
  • 项目类别:
Sex/Drug Tourism at the US/Mexico Border: Social Network Influences on HIV Risk.
美国/墨西哥边境的性/毒品旅游:社交网络对艾滋病毒风险的影响。
  • 批准号:
    8071496
  • 财政年份:
    2010
  • 资助金额:
    $ 1.39万
  • 项目类别:
Sex/Drug Tourism at the US/Mexico Border: Social Network Influences on HIV Risk.
美国/墨西哥边境的性/毒品旅游:社交网络对艾滋病毒风险的影响。
  • 批准号:
    8139697
  • 财政年份:
    2010
  • 资助金额:
    $ 1.39万
  • 项目类别:
Sex/Drug Tourism at the US/Mexico Border: Social Network Influences on HIV Risk.
美国/墨西哥边境的性/毒品旅游:社交网络对艾滋病毒风险的影响。
  • 批准号:
    8717623
  • 财政年份:
    2010
  • 资助金额:
    $ 1.39万
  • 项目类别:
Gender differences in perceived costs of safer injection among injection drug use
注射吸毒者对更安全注射的感知成本存在性别差异
  • 批准号:
    7492584
  • 财政年份:
    2008
  • 资助金额:
    $ 1.39万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 1.39万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 1.39万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 1.39万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 1.39万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 1.39万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 1.39万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 1.39万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 1.39万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 1.39万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 1.39万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了